AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BCAL DIAGNOSTICS LTD

0.087

-0.003-3.33%

Volume:360.69K

Turnover:32.27K

Market Cap:32.02M

PE:-4.34

High:0.092

Open:0.092

Low:0.087

Close:0.090

52wk High:0.155

52wk Low:0.052

Shares:368.07M

Float Shares:202.44M

Volume Ratio:1.45

T/O Rate:0.18%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.020

EPS(LYR):-0.020

ROE:-273.29%

ROA:-50.29%

PB:-38.76

PE(LYR):-4.35

Loading ...

Overview Company News Filings

3 Dividend Aristocrats Still Worth Watching As Rates Stay Higher For Longer

Simply Wall St.

Goldman Sachs Adjusts Price Target on Becton, Dickinson and Company to $152 From $150, Maintains Neutral Rating

MT Newswires Live

Waters Seen Benefiting From BD Turnaround, Pharma Manufacturing Tailwinds, RBC Says

MT Newswires Live

BCAL to Acquire Shares in Genetic Signatures

Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $180 From $190

MT Newswires Live

BCAL to Acquire Shares in Genetic Signatures

BCAL Diagnostics Ltd - to Buy 10.2% Stake in Genetic Signatures for A$1.39 Mln

THOMSON REUTERS

Bcal Diagnostics Secures A$4.9 Million Under Convertible Note Facility

BCAL Diagnostics - Secures A$4.9 Mln Under Convertible Note Facility

THOMSON REUTERS

BCAL Diagnostics - Expects Remaining FY26 R&D Tax Offset in October 2026

THOMSON REUTERS

Is Vizient’s Nod to BD CentroVena One Quietly Reframing Becton Dickinson’s (BDX) Competitive Moat?

Simply Wall St.

Becton, Dickinson Secures Vizient Recognition for CentroVena One Insertion System

MT Newswires Live

Becton Dickinson (BDX) Stock Could Be 20.6% Undervalued After Class I Spinal Tray Recalls

Simply Wall St.

BUZZ-Australia's BCAL Diagnostics soars on development of new blood test for breast cancer

BofA Adjusts Price Target on Becton, Dickinson and Company to $170 From $177

MT Newswires Live

A Look At Becton Dickinson (BDX) Valuation After The Elyra Kidney Stone Care Launch

Simply Wall St.

BCAL Diagnostics Ltd-Validation Agreement Signed With Sonic USA, for Breastest V2

THOMSON REUTERS

BCAL Diagnostics - Validation to Be Conducted in Clia-Certified Sonic Laboratory in Austin, Texas

THOMSON REUTERS

BCAL Diagnostics - Sonic Healthcare USA May Negotiate Commercial Licence for Breastestplus Version 2 Post-Validation

THOMSON REUTERS

Becton, Dickinson Launches Elyra Thulium Fiber Laser System for Kidney Stone Management

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/BDX.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BDX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BDX.AU\",,,,,undefined,":{"symbol":"BDX.AU","market":"AU","secType":"STK","nameCN":"BCAL DIAGNOSTICS LTD","latestPrice":0.087,"timestamp":1790921520000,"preClose":0.09,"halted":0,"volume":360690,"delay":0,"changeRate":-0.03333333333333337,"nameEN":"BCAL DIAGNOSTICS LTD","floatShares":202437334,"shares":368067640,"eps":-0.020055,"marketStatus":"Closed","change":-0.003,"latestTime":"10-02 16:12:00 AEST","open":0.092,"high":0.092,"low":0.087,"amount":32266,"amplitude":0.055556,"askPrice":0.092,"askSize":308081,"bidPrice":0.087,"bidSize":2697,"shortable":3,"etf":0,"ttmEps":-0.020055,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791154800000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.09,"openAndCloseTimeList":[[1790899200000,1790920800000]],"volumeRatio":1.447609,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"BDX.AU","preClose":0.09,"auctionPrice":0.092,"auctionVolume":6000,"auctionTime":1790920800756,"referencePrice":0.087,"referenceTime":1790937003087,"auction":3,"marketStatus":"盘后竞价","timestamp":1790920800756}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BDX.AU\",,,,,undefined,":{"symbol":"BDX.AU","floatShares":202437334,"roa":"-50.29%","roe":"-273.29%","lyrEps":-0.02,"volumeRatio":1.447609,"shares":368067640,"dividePrice":0,"high":0.092,"amplitude":0.055556,"preClose":0.09,"low":0.087,"week52Low":0.052,"pbRate":"-38.76","psRate":"13.61","week52High":0.155,"institutionHeld":0,"latestPrice":0.087,"committee":-0.982644,"eps":-0.020055,"divideRate":0,"volume":360690,"delay":0,"ttmEps":-0.020055,"open":0.092,"prevYearClose":0.105,"prevWeekClose":0.081,"prevMonthClose":0.09,"prevQuarterClose":0.09,"fiveDayClose":0.081,"twentyDayClose":0.069,"sixtyDayClose":0.073},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BDX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-03","symbol":"BDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788393600000,"name":null,"time":"","dateTimestamp":1788357600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BDX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BDX.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651046482","title":"3 Dividend Aristocrats Still Worth Watching As Rates Stay Higher For Longer","url":"https://stock-news.laohu8.com/highlight/detail?id=2651046482","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651046482?lang=en_us&edition=fundamental","pubTime":"2026-07-15 06:25","pubTimestamp":1784067949,"startTime":"0","endTime":"0","summary":"With Fed Chair Kevin Warsh signaling that interest rates may stay higher for longer, inflation still above the 2% target, and oil prices jumping after renewed tensions in the Strait of Hormuz, many investors are reassessing how reliable their income stocks really are. Dividend Aristocrats, with long records of raising payouts and a focus on financial discipline, can look appealing when volatility and inflation risks rise together. This article walks through 3 stocks from our Dividend...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/3-dividend-aristocrats-still-worth-watching-as-rates-stay-hi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/3-dividend-aristocrats-still-worth-watching-as-rates-stay-hi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0472753341.HKD","LU0289739343.SGD","LU0006061336.USD","LU0289961442.SGD","LU1892829315.USD","IE00BSNM7G36.USD","LU0130103400.USD","LU0477156797.USD","LU1894683348.USD","LU0130518102.USD","LU1854103824.USD","LU0868494617.USD","IHI","LU0266013472.USD","LU1571399168.USD","LU1854104046.USD","IE00B19Z3581.USD","LU1150488135.SGD","LU0648000940.SGD","LU0057025933.USD","BK4585","LU1150488218.USD","LU1894683264.USD","LU1261432733.SGD","LU0058720904.USD","LU0162691827.USD","CGDV","BK4588","LU0289739699.SGD","CLIX","LU1489326972.SGD","LU0069063385.USD","BK7067","LU0878866978.SGD","LU0689626769.HKD","LU0068578508.USD","LU0985489474.SGD","BDX.AU","LU0072461881.USD","VIG","EQRR","LU0433182093.SGD","LU0511384066.AUD","STE","LU0124676726.USD","BDX","IE00B19Z3B42.SGD","LU0985320562.USD","BK4196","CI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651170093","title":"Goldman Sachs Adjusts Price Target on Becton, Dickinson and Company to $152 From $150, Maintains Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2651170093","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651170093?lang=en_us&edition=fundamental","pubTime":"2026-07-14 19:31","pubTimestamp":1784028710,"startTime":"0","endTime":"0","summary":"Becton, Dickinson and Company (BDX) has an average rating of overweight and mean price target of $172.73, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic re","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1201861165.SGD","BK4588","LU0289739343.SGD","LU0878866978.SGD","LU0985489474.SGD","LU0072461881.USD","LU0006061336.USD","LU0130103400.USD","LU1059921491.USD","LU0162691827.USD","BK4504","BDX","LU1894683264.USD","LU0648000940.SGD","BK7067","LU1150488218.USD","IE00BFXG1179.USD","LU0130518102.USD","LU0068578508.USD","LU0289961442.SGD","BK4585","LU1894683348.USD","LU0266013472.USD","LU0477156797.USD","LU1854103824.USD","BDX.AU","LU0511384066.AUD","LU0985320562.USD","LU1854104046.USD","BK4082","IHI","LU0433182093.SGD","LU1489326972.SGD","LU1571399168.USD","LU1150488135.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650292125","title":"Waters Seen Benefiting From BD Turnaround, Pharma Manufacturing Tailwinds, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2650292125","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650292125?lang=en_us&edition=fundamental","pubTime":"2026-07-09 20:23","pubTimestamp":1783599816,"startTime":"0","endTime":"0","summary":"Waters  could unlock stronger growth by turning around the recent acquired Becton Dickinson  biosciences and diagnostics businesses while benefiting from resilient demand tied to drug manufacturing, RBC Capital said in a Thursday note.Analysts said the acquired assets were under-managed rather than structurally weak and sees Waters' management applying its turnaround expertise to revive growth.RBC also expects the company to benefit from industry consolidation opportunities and its roughly 15% exposure to pharmaceutical manufacturing, which could gain from US re-shoring trends.RBC initiated coverage with an outperform rating and a $435 price target.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BD","LU1150488218.USD","IE00BFXG1179.USD","LU2404859667.USD","WAT","LU0006061336.USD","BDX.AU","LU0985489474.SGD","LU1854104046.USD","BK7067","LU1894683348.USD","BK4504","LU0511384066.AUD","BK4588","BDX","LU0266013472.USD","LU0130103400.USD","LU0985320562.USD","LU1489326972.SGD","LU1894683264.USD","IHI","BK4585","LU0690374615.EUR","LU0130518102.USD","LU1201861165.SGD","GB00B4QBRK32.GBP","LU1854103824.USD","LU1059921491.USD","LU1571399168.USD","LU0072461881.USD","LU0690374961.EUR","LU0289961442.SGD","LU2404859741.USD","LU0477156797.USD","LU2413666699.HKD","WAT.AU","BK4121","GB00B4LPDJ14.GBP","LU1150488135.SGD","BK4082","LU0289739343.SGD","BK7118","LU0648000940.SGD","LU0433182093.SGD","LU0068578508.USD","LU0878866978.SGD","LU1721428933.USD","LU0347712357.USD","LU0162691827.USD","LU2413666426.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649446988","title":"BCAL to Acquire Shares in Genetic Signatures","url":"https://stock-news.laohu8.com/highlight/detail?id=2649446988","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649446988?lang=en_us&edition=fundamental","pubTime":"2026-07-07 16:38","pubTimestamp":1783413518,"startTime":"0","endTime":"0","summary":"July 2 (Reuters) - BCAL Diagnostics Ltd::*BCAL TO ACQUIRE SHARES IN GENETIC SIGNATURES,GSS*TO BUY 10.2% STAKE IN GENETIC SIGNATURES FOR A$1.39 MILLION*Further company coverage: BDX.AX* ((Reuters.Brief","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nRSDXrYJs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","GSS.AU","BK7501","BK7048","BDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649624217","title":"Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $180 From $190","url":"https://stock-news.laohu8.com/highlight/detail?id=2649624217","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649624217?lang=en_us&edition=fundamental","pubTime":"2026-07-06 21:21","pubTimestamp":1783344069,"startTime":"0","endTime":"0","summary":"Becton, Dickinson and Company (BDX) has an average rating of overweight and mean price target of $172.55, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic re","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0433182093.SGD","LU0511384066.AUD","LU0162691827.USD","BDX.AU","LU1571399168.USD","LU1201861165.SGD","BDX","IE00BFXG1179.USD","LU0068578508.USD","LU0985489474.SGD","LU1894683348.USD","LU0289739343.SGD","IHI","LU0878866978.SGD","BK4585","BK4588","BK4504","LU0072461881.USD","BK7067","LU0266013472.USD","LU0477156797.USD","LU1854103824.USD","LU1854104046.USD","LU1489326972.SGD","LU0289961442.SGD","LU0130518102.USD","LU0648000940.SGD","LU1894683264.USD","LU0006061336.USD","LU0985320562.USD","LU1150488135.SGD","LU1059921491.USD","LU0130103400.USD","BK4082","LU1150488218.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648578901","title":"BCAL to Acquire Shares in Genetic Signatures","url":"https://stock-news.laohu8.com/highlight/detail?id=2648578901","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648578901?lang=en_us&edition=fundamental","pubTime":"2026-07-02 09:34","pubTimestamp":1782956083,"startTime":"0","endTime":"0","summary":"BRIEF-BCAL To Acquire Shares In Genetic SignaturesJuly 2 (Reuters)-BCAL Diagnostics LtdBDX.AX:BCAL TO ACQUIRE SHARES IN GENETIC SIGNATURES,GSSTO BUY 10.2% STAKE IN GENETIC SIGNATURES FOR A$1.39 MILLIONFurther company coverage:BDX.AX","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nTUE20NLFQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","GSS.AU","BK7048","BDX.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648852202","title":"BCAL Diagnostics Ltd - to Buy 10.2% Stake in Genetic Signatures for A$1.39 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2648852202","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648852202?lang=en_us&edition=fundamental","pubTime":"2026-07-02 08:04","pubTimestamp":1782950657,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nTUE20NLFQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","GSS.AU","BK7501","BDX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647449663","title":"Bcal Diagnostics Secures A$4.9 Million Under Convertible Note Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2647449663","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647449663?lang=en_us&edition=fundamental","pubTime":"2026-06-29 09:27","pubTimestamp":1782696449,"startTime":"0","endTime":"0","summary":"BRIEF-Bcal Diagnostics Secures A$4.9 Million Under Convertible Note FacilityJune 29 (Reuters)-BCAL Diagnostics LtdBDX.AX:SECURES A$4.9 MILLION UNDER CONVERTIBLE NOTE FACILITYEXPECTS REMAINING FY26 RD TAX OFFSET IN OCTOBER 2026Further company coverage:BDX.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nFWN42Y123:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647334978","title":"BCAL Diagnostics - Secures A$4.9 Mln Under Convertible Note Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2647334978","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647334978?lang=en_us&edition=fundamental","pubTime":"2026-06-29 07:57","pubTimestamp":1782691058,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260628:nFWN42Y123:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BDX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647234978","title":"BCAL Diagnostics - Expects Remaining FY26 R&D Tax Offset in October 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2647234978","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647234978?lang=en_us&edition=fundamental","pubTime":"2026-06-29 07:57","pubTimestamp":1782691058,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260628:nFWN42Y123:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647766349","title":"Is Vizient’s Nod to BD CentroVena One Quietly Reframing Becton Dickinson’s (BDX) Competitive Moat?","url":"https://stock-news.laohu8.com/highlight/detail?id=2647766349","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647766349?lang=en_us&edition=fundamental","pubTime":"2026-06-29 06:14","pubTimestamp":1782684892,"startTime":"0","endTime":"0","summary":"Earlier this month, Becton, Dickinson and Company announced that its BD CentroVena One Insertion System received an Innovative Technology contract from Vizient, recognizing the all-in-one central venous catheter insertion system for its potential to simplify central line placement and enhance patient and clinician safety.\nThis endorsement from Vizient’s expert hospital councils highlights CentroVena One’s differentiated workflow and safety advantages, which could influence purchasing...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/is-vizients-nod-to-bd-centrovena-one-quietly-reframing-becto","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/is-vizients-nod-to-bd-centrovena-one-quietly-reframing-becto","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0130103400.USD","LU0648000940.SGD","LU0072461881.USD","LU0878866978.SGD","LU0266013472.USD","LU1571399168.USD","LU0006061336.USD","LU1150488218.USD","LU1201861165.SGD","LU0985489474.SGD","IE00BFXG1179.USD","LU1894683264.USD","BDX","BK4082","LU1854104046.USD","LU1854103824.USD","LU0289961442.SGD","LU1150488135.SGD","BDX.AU","LU0130518102.USD","LU1059921491.USD","LU0068578508.USD","BK4585","BK4588","LU0289739343.SGD","BD","BK7067","LU1894683348.USD","LU0511384066.AUD","LU0985320562.USD","LU0162691827.USD","LU1489326972.SGD","LU0433182093.SGD","LU0477156797.USD","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645833309","title":"Becton, Dickinson Secures Vizient Recognition for CentroVena One Insertion System","url":"https://stock-news.laohu8.com/highlight/detail?id=2645833309","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645833309?lang=en_us&edition=fundamental","pubTime":"2026-06-23 19:15","pubTimestamp":1782213326,"startTime":"0","endTime":"0","summary":"Becton, Dickinson  said Tuesday that Vizient granted an Innovative Technology contract to its BD CentroVena One central venous catheter insertion system.The medical technology company said the contract, awarded after an evaluation by hospital experts on Vizient's client-led councils, recognizes products with the potential to enhance healthcare delivery.The integrated device simplifies the procedure by combining the guidewire, needle, syringe, and catheter, resulting in 30% fewer steps and up to a 50% shorter procedure time, the company added.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1571399168.USD","LU1894683348.USD","BK4504","IE00BFXG1179.USD","LU1854104046.USD","BK4585","LU0985320562.USD","LU0068578508.USD","LU0130103400.USD","LU0477156797.USD","LU0072461881.USD","LU0433182093.SGD","LU1894683264.USD","LU0130518102.USD","LU1489326972.SGD","BK4588","LU0878866978.SGD","LU0006061336.USD","LU0289961442.SGD","LU1201861165.SGD","BK4082","LU0511384066.AUD","BDX","LU1854103824.USD","LU0289739343.SGD","BDX.AU","LU0162691827.USD","LU1059921491.USD","BK7067","LU1150488218.USD","LU0648000940.SGD","LU1150488135.SGD","LU0266013472.USD","LU0985489474.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644418065","title":"Becton Dickinson (BDX) Stock Could Be 20.6% Undervalued After Class I Spinal Tray Recalls","url":"https://stock-news.laohu8.com/highlight/detail?id=2644418065","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644418065?lang=en_us&edition=fundamental","pubTime":"2026-06-20 02:49","pubTimestamp":1781894967,"startTime":"0","endTime":"0","summary":"Becton Dickinson (BDX) has initiated several voluntary Class I sub-recalls of BD Spinal Tray products across the US after FDA inspections flagged acceptance testing deficiencies at a supplier of bupivacaine in dextrose.\nSee our latest analysis for Becton Dickinson.\nBecton Dickinson's share price has been under pressure, with the stock down 26.14% on a year to date share price return and 6.59% over 90 days, even though the 1 year total shareholder return is 11.34%. This suggests momentum has...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/becton-dickinson-bdx-stock-could-be-206-undervalued-after-cl","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/becton-dickinson-bdx-stock-could-be-206-undervalued-after-cl","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0162691827.USD","BK7067","LU0130103400.USD","LU1059921491.USD","LU0068578508.USD","LU1571399168.USD","LU1854104046.USD","BK4504","LU0289739343.SGD","LU1489326972.SGD","BDX.AU","LU0985489474.SGD","LU0477156797.USD","LU0878866978.SGD","LU1894683264.USD","LU0006061336.USD","LU0130518102.USD","LU0266013472.USD","LU0433182093.SGD","LU0072461881.USD","LU1854103824.USD","LU1201861165.SGD","LU1150488218.USD","BK4082","LU0985320562.USD","IE00BFXG1179.USD","LU0511384066.AUD","LU0648000940.SGD","BK4588","BK4585","LU1150488135.SGD","BDX","LU0289961442.SGD","LU1894683348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644774521","title":"BUZZ-Australia's BCAL Diagnostics soars on development of new blood test for breast cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2644774521","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644774521?lang=en_us&edition=fundamental","pubTime":"2026-06-18 13:08","pubTimestamp":1781759280,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's BCAL Diagnostics soars on development of new blood test for breast cancer** Shares of Australia's BCAL Diagnostics BDX.AX gain as much as 133.3% to A$0.140, set for biggest gain since August 2, 2023** Stock hit its highest level since January 16** Biotechnology co develops a blood test, \"BREASTEST\" monitor - a simpler way for women to be evaluated for local recurrence of breast cancer** Co's preliminary findings in women aged 50 years and above show the test identified 20 of 23 confirmed local recurrence cases** Adds, BREASTEST will enter the market as an adjunct to imaging, while it plans to eventually develop it as a standalone surveillance test** 11.5 million shares trade hands vs 30-day average of 145,162 shares** Shares down 12.38% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nL4N42Q0CM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642600342","title":"BofA Adjusts Price Target on Becton, Dickinson and Company to $170 From $177","url":"https://stock-news.laohu8.com/highlight/detail?id=2642600342","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642600342?lang=en_us&edition=fundamental","pubTime":"2026-06-12 20:02","pubTimestamp":1781265722,"startTime":"0","endTime":"0","summary":"Becton, Dickinson and Company (BDX) has an average rating of overweight and mean price target of $173.45, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic re","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1571399168.USD","LU1894683348.USD","BK4504","IE00BFXG1179.USD","LU1854104046.USD","BK4585","LU0985320562.USD","LU0068578508.USD","LU0130103400.USD","LU0477156797.USD","LU0072461881.USD","LU0433182093.SGD","LU1894683264.USD","LU0130518102.USD","LU1489326972.SGD","BK4588","LU0878866978.SGD","LU0006061336.USD","LU0289961442.SGD","LU1201861165.SGD","BK4082","LU0511384066.AUD","BDX","LU1854103824.USD","LU0289739343.SGD","BDX.AU","LU0162691827.USD","LU1059921491.USD","BK7067","LU1150488218.USD","LU0648000940.SGD","LU1150488135.SGD","LU0266013472.USD","LU0985489474.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640642967","title":"A Look At Becton Dickinson (BDX) Valuation After The Elyra Kidney Stone Care Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2640642967","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640642967?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:21","pubTimestamp":1780345273,"startTime":"0","endTime":"0","summary":"Why the Elyra launch matters for Becton Dickinson (BDX) shareholders\nBecton Dickinson (BDX) has introduced its Elyra Thulium Fiber Laser System for kidney stone care, rounding out its urologic portfolio and drawing fresh attention to how this product expansion might influence the stock.\nSee our latest analysis for Becton Dickinson.\nAt a share price of US$147.12, Becton Dickinson has seen its share price fall over the past quarter and year to date, while the 1 year total shareholder return...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/a-look-at-becton-dickinson-bdx-valuation-after-the-elyra-kid","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/a-look-at-becton-dickinson-bdx-valuation-after-the-elyra-kid","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1854103824.USD","LU0289739343.SGD","BK4082","LU0006061336.USD","LU1894683348.USD","LU0648000940.SGD","LU1489326972.SGD","LU1854104046.USD","BK4585","LU0072461881.USD","BDX","BDX.AU","LU1150488135.SGD","LU1894683264.USD","IE00BFXG1179.USD","LU0433182093.SGD","LU0511384066.AUD","LU0985320562.USD","LU0266013472.USD","LU0878866978.SGD","LU0985489474.SGD","LU1150488218.USD","LU1201861165.SGD","BK4588","LU0130518102.USD","LU1059921491.USD","SGY","LU0477156797.USD","LU0068578508.USD","BK7067","BK4504","LU0289961442.SGD","LU0130103400.USD","LU0162691827.USD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638663434","title":"BCAL Diagnostics Ltd-Validation Agreement Signed With Sonic USA, for Breastest V2","url":"https://stock-news.laohu8.com/highlight/detail?id=2638663434","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638663434?lang=en_us&edition=fundamental","pubTime":"2026-05-28 06:25","pubTimestamp":1779920721,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nTUE2TN39:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BDX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638634349","title":"BCAL Diagnostics - Validation to Be Conducted in Clia-Certified Sonic Laboratory in Austin, Texas","url":"https://stock-news.laohu8.com/highlight/detail?id=2638634349","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638634349?lang=en_us&edition=fundamental","pubTime":"2026-05-28 06:25","pubTimestamp":1779920721,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nTUE2TN39:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BDX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638345634","title":"BCAL Diagnostics - Sonic Healthcare USA May Negotiate Commercial Licence for Breastestplus Version 2 Post-Validation","url":"https://stock-news.laohu8.com/highlight/detail?id=2638345634","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638345634?lang=en_us&edition=fundamental","pubTime":"2026-05-28 06:25","pubTimestamp":1779920721,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nTUE2TN39:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BDX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637334103","title":"Becton, Dickinson Launches Elyra Thulium Fiber Laser System for Kidney Stone Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2637334103","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637334103?lang=en_us&edition=fundamental","pubTime":"2026-05-21 19:58","pubTimestamp":1779364688,"startTime":"0","endTime":"0","summary":"Becton, Dickinson  said Thursday it has introduced the Elyra Thulium Fiber Laser System for kidney stone and soft tissue procedures in urology.The company said the system improves stone dusting efficiency and reduces stone movement during procedures.The platform is available in two versions, Elyra and Elyra Plus, offering different configurations based on operational needs, the company said.Becton, Dickinson said it completed initial clinical cases in the US, where users highlighted the system's intuitive interface and integrated safety features.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1201861165.SGD","LU1150488135.SGD","LU0289739343.SGD","BK4504","LU0648000940.SGD","LU1489326972.SGD","LU1854104046.USD","LU0878866978.SGD","LU0130518102.USD","LU0477156797.USD","LU0985320562.USD","LU0130103400.USD","LU0266013472.USD","LU0006061336.USD","BDX","BK4588","LU1571399168.USD","BK7067","BDX.AU","LU0511384066.AUD","LU0289961442.SGD","LU1150488218.USD","LU0162691827.USD","LU0433182093.SGD","IE00BFXG1179.USD","LU0985489474.SGD","LU0068578508.USD","LU1894683348.USD","BK4585","LU0072461881.USD","BK4082","LU1894683264.USD","LU1059921491.USD","SGY","LU1854103824.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":56,"code":"91000000","status":"200"}]}}